These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 26121332)

  • 41. Evaluation of secondary amide replacements in a series of CCR5 antagonists as a means to increase intrinsic membrane permeability. Part 1: Optimization of gem-disubstituted azacycles.
    Lemoine RC; Petersen AC; Setti L; Wanner J; Jekle A; Heilek G; deRosier A; Ji C; Berry P; Rotstein D
    Bioorg Med Chem Lett; 2010 Jan; 20(2):704-8. PubMed ID: 20004099
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proteolytic fragments of anti-HIV and anti-tumor proteins MAP30 and GAP31 are biologically active.
    Huang PL; Sun Y; Chen HC; Kung HF; Lee-Huang S
    Biochem Biophys Res Commun; 1999 Sep; 262(3):615-23. PubMed ID: 10471373
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-HIV agents that selectively target retroviral nucleocapsid protein zinc fingers without affecting cellular zinc finger proteins.
    Huang M; Maynard A; Turpin JA; Graham L; Janini GM; Covell DG; Rice WG
    J Med Chem; 1998 Apr; 41(9):1371-81. PubMed ID: 9554870
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of chloroquine on membrane permeability in yeast--release of cellular coproporphyrin.
    Kotal P; Kotyk A; Jirsa M; Kordac V
    Int J Biochem; 1988; 20(5):539-42. PubMed ID: 3286314
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improving cell penetration of helical peptides stabilized by N-terminal crosslinked aspartic acids.
    Zhao H; Jiang Y; Tian Y; Yang D; Qin X; Li Z
    Org Biomol Chem; 2017 Jan; 15(2):459-464. PubMed ID: 27924991
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cell-Permeable Peptides Containing Cycloalanine Residues.
    Wu H; Mousseau G; Mediouni S; Valente ST; Kodadek T
    Angew Chem Int Ed Engl; 2016 Oct; 55(41):12637-42. PubMed ID: 27529332
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Using molecular dynamics simulations to prioritize and understand AI-generated cell penetrating peptides.
    Tran DP; Tada S; Yumoto A; Kitao A; Ito Y; Uzawa T; Tsuda K
    Sci Rep; 2021 May; 11(1):10630. PubMed ID: 34017051
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Membrane activity of a supramolecular peptide-based chemotherapeutic enhancer.
    Xu D; Jiang L; DeRidder L; Elmore B; Bukhari M; Wei Q; Samways DS; Dong H
    Mol Biosyst; 2016 Aug; 12(9):2695-9. PubMed ID: 27397555
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of alpha-aminoisobutyric acid as an internal indicator in chick plasma amino acid studies.
    Smith RE
    J Nutr; 1966 Jul; 89(3):276-82. PubMed ID: 5913936
    [No Abstract]   [Full Text] [Related]  

  • 50. [Antiviral chemical preparations of selective permeability].
    Vopr Virusol; 1979; (6):677. PubMed ID: 524864
    [No Abstract]   [Full Text] [Related]  

  • 51. [Not Available].
    Walter M
    MMW Fortschr Med; 2022 Sep; 164(16):64. PubMed ID: 36123492
    [No Abstract]   [Full Text] [Related]  

  • 52. Formation of bacterial pilus-like nanofibres by designed minimalistic self-assembling peptides.
    Guterman T; Kornreich M; Stern A; Adler-Abramovich L; Porath D; Beck R; Shimon LJW; Gazit E
    Nat Commun; 2016 Nov; 7():13482. PubMed ID: 27853136
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of anti-HIV peptides based on a viral capsid protein.
    Mizuguchi T; Ohashi N; Matsumoto D; Hashimoto C; Nomura W; Yamamoto N; Murakami T; Tamamura H
    Biopolymers; 2017 Jan; 108(1):. PubMed ID: 27428649
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Conjugation of cell-penetrating peptides leads to identification of anti-HIV peptides from matrix proteins.
    Narumi T; Komoriya M; Hashimoto C; Wu H; Nomura W; Suzuki S; Tanaka T; Chiba J; Yamamoto N; Murakami T; Tamamura H
    Bioorg Med Chem; 2012 Feb; 20(4):1468-74. PubMed ID: 22277590
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The capsid protein of human immunodeficiency virus: designing inhibitors of capsid assembly.
    Neira JL
    FEBS J; 2009 Nov; 276(21):6110-7. PubMed ID: 19825045
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Medicinal chemistry strategies of targeting HIV-1 capsid protein for antiviral treatment.
    Xu S; Sun L; Huang B; Liu X; Zhan P
    Future Med Chem; 2020 Jul; 12(14):1281-1284. PubMed ID: 32483985
    [No Abstract]   [Full Text] [Related]  

  • 57. α-Aminoisobutyric acid incorporation induces cell permeability and antiviral activity of HIV-1 major homology region fragments.
    Lampel A; Elis E; Guterman T; Shapira S; Marco P; Bacharach E; Gazit E
    Chem Commun (Camb); 2015 Aug; 51(62):12349-52. PubMed ID: 26121332
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of Ala replacement with Aib in amphipathic cell-penetrating peptide on oligonucleotide delivery into cells.
    Wada S; Hashimoto Y; Kawai Y; Miyata K; Tsuda H; Nakagawa O; Urata H
    Bioorg Med Chem; 2013 Dec; 21(24):7669-73. PubMed ID: 24216093
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.